LU78363A1 - - Google Patents

Info

Publication number
LU78363A1
LU78363A1 LU78363A LU78363A LU78363A1 LU 78363 A1 LU78363 A1 LU 78363A1 LU 78363 A LU78363 A LU 78363A LU 78363 A LU78363 A LU 78363A LU 78363 A1 LU78363 A1 LU 78363A1
Authority
LU
Luxembourg
Application number
LU78363A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU78363A1 publication Critical patent/LU78363A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
LU78363A 1976-10-22 1977-10-21 LU78363A1 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB44008/76A GB1561345A (en) 1976-10-22 1976-10-22 8 - azapuring - 6 - ones

Publications (1)

Publication Number Publication Date
LU78363A1 true LU78363A1 (cs) 1978-06-12

Family

ID=10431345

Family Applications (1)

Application Number Title Priority Date Filing Date
LU78363A LU78363A1 (cs) 1976-10-22 1977-10-21

Country Status (15)

Country Link
US (1) US4167568A (cs)
JP (1) JPS5395993A (cs)
AU (1) AU510478B2 (cs)
BE (1) BE859987A (cs)
CA (1) CA1111027A (cs)
CH (1) CH628898A5 (cs)
DE (1) DE2747199A1 (cs)
DK (1) DK142766B (cs)
GB (1) GB1561345A (cs)
HU (1) HU180009B (cs)
IE (1) IE45810B1 (cs)
LU (1) LU78363A1 (cs)
NL (1) NL7711332A (cs)
SE (1) SE7711836L (cs)
ZA (1) ZA776258B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
BR9816155B1 (pt) 1997-11-12 2010-07-27 imidazotriazinonas 2-fenil-substituìdas como inibidores de fosfodiesterase, bem como medicamento e uso farmacêutico compreendendo as mesmas.
ATE348618T1 (de) * 2001-05-09 2007-01-15 Bayer Healthcare Ag Neue verwendung von 2-(2-ethoxy-5-(4-methyl- piperazin-1-sulfonyl)-phenyl)-5-methyl-7-propyl 3h-imidazo(5,1-f)(1,2,4)triazin-4-on
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
KR20080056250A (ko) * 2005-09-29 2008-06-20 바이엘 헬스케어 아게 비뇨기 장애의 치료를 위한 pde 억제제 및 이들의 조합
TWI845600B (zh) 2019-01-24 2024-06-21 美商普羅米修斯生物科學股份有限公司 Gpr35調節劑
WO2022020617A1 (en) * 2020-07-23 2022-01-27 Prometheus Biosciences, Inc. Therapeutic agents targeting gpr35

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421970A (en) * 1973-06-12 1976-01-21 May & Baker Ltd 8-azapurin-6-one derivatives
GB1493685A (en) * 1970-12-15 1977-11-30 May & Baker Ltd 8-azapurinones
US3819631A (en) * 1970-12-15 1974-06-25 May & Baker Ltd Azapurinones
US4052390A (en) * 1973-06-12 1977-10-04 May & Baker Limited Azapurinones

Also Published As

Publication number Publication date
CH628898A5 (fr) 1982-03-31
DE2747199A1 (de) 1978-04-27
DK467177A (cs) 1978-04-23
SE7711836L (sv) 1978-04-23
BE859987A (fr) 1978-04-21
JPS5395993A (en) 1978-08-22
HU180009B (en) 1983-01-28
AU510478B2 (en) 1980-06-26
DK142766B (da) 1981-01-19
DK142766C (cs) 1981-08-17
IE45810B1 (en) 1982-12-01
CA1111027A (fr) 1981-10-20
ZA776258B (en) 1978-07-26
NL7711332A (nl) 1978-04-25
IE45810L (en) 1978-04-22
US4167568A (en) 1979-09-11
AU2991177A (en) 1979-04-26
GB1561345A (en) 1980-02-20

Similar Documents

Publication Publication Date Title
CH640381GA3 (cs)
DK142766C (cs)
JPS5535614B2 (cs)
JPS5639110Y2 (cs)
JPS5340009U (cs)
JPS5511969Y2 (cs)
JPS556060B2 (cs)
JPS5378388U (cs)
JPS5292154U (cs)
JPS5655912Y2 (cs)
CS178369B1 (cs)
CS192684B1 (cs)
JPS52104090U (cs)
JPS52129774U (cs)
JPS52108687U (cs)
CS177436B1 (cs)
CS178368B1 (cs)
CS186526B1 (cs)
CH614801A5 (cs)
BG23087A1 (cs)
DD122437A1 (cs)
DD123415A1 (cs)
DD123524A1 (cs)
CH612082A5 (cs)
DD123555A1 (cs)